Treatment patterns and persistence rates with anti‐vascular endothelial growth factor treatment for diabetic macular oedema in the UK: A real‐world study-Reference-Cited by-同舟云学术

Treatment patterns and persistence rates with anti‐vascular endothelial growth factor treatment for diabetic macular oedema in the UK: A real‐world study

Published:2021-12-15 Issue: Volume: Page:
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet Med

Author:

Peto Tunde¹^ORCID,Akerele Toks²,Sagkriotis Alexandros³,Zappacosta Sofia⁴,Clemens Andreas³⁵,Chakravarthy Usha¹

Affiliation:

1. Centre for Public Health Queen's University Belfast Belfast UK

2. Hinchingbrooke Hospital Huntingdon UK

3. Novartis Pharma AG Basel Switzerland

4. IQVIA Real World Insights Basel Switzerland

5. Department of Cardiology and Angiology I Faculty of Medicine Heart Center Freiburg UniversityUniversity of Freiburg Freiburg Germany

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dme.14746

Reference27 articles.

1. Diabetes UK. Diabetes prevalence 2019. 2019. Accessed January 19 2021.https://www.diabetes.org.uk/professionals/position‐statements‐reports/statistics/diabetes‐prevalence‐2019

2. Diabetic macular edema;Musat O;Rom J Ophthalmol,2015

3. The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema;Klein R;Ophthalmology,1989

4. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies;Ciulla TA;Diabetes Care,2003

5. Diagnosed diabetic retinopathy in France, Italy, Spain, and the United Kingdom;Rubino A;Prim Care Diabetes,2007

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two different initial treatment regimens of Conbercept in diabetic macular edema: 12-month results from a multicenter randomized controlled study;Photodiagnosis and Photodynamic Therapy;2023-12

2. Remote Monitoring of Visual Function in Patients with Maculopathy: The Aphelion Study;Ophthalmology and Therapy;2023-11-28

3. From randomised controlled trials to real-world data: Clinical evidence to guide management of diabetic macular oedema;Progress in Retinal and Eye Research;2023-11

4. Functional Outcomes of Brolucizumab-Induced Intraocular Inflammation Involving the Posterior Segment—A Meta-Analysis and Systematic Review;Journal of Clinical Medicine;2023-07-14

5. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-06-27